IMAC IMAC Holdings

IMAC Holdings to Present at Fall Harvest – Best Ideas from the Buy-Side on October 5, 2021

IMAC Holdings to Present at Fall Harvest – Best Ideas from the Buy-Side on October 5, 2021

BRENTWOOD, Tenn, Sept. 28, 2021 (GLOBE NEWSWIRE) -- IMAC Holdings, Inc. (Nasdaq: IMAC) (“IMAC” or the “Company”), a provider of innovative medical advancements and care specializing in regenerative rehabilitation orthopedic treatments without the use of surgery or opioids, has been invited to present at the Fall Harvest – Best Ideas from the Buy-Side conference, which is being held virtually starting October 5, 2021.

IMAC CEO Jeff Ervin is scheduled to present on Tuesday, October 5 at 11:30 ET. Management will be available for one-on-one meetings to be held throughout the conference. Investors can To receive additional information, request an invitation or to schedule a one-on-one meeting, please email .

About the Fall Harvest - Best Ideas from the Buy-Side Conference

The Fall Harvest - MicroCap Rodeo is back with its fourth “Best Ideas” conference. This conference is a virtual conference that brings you the top 35 best ideas from the buy side. Qualified institutional investors recommended each of the 35 companies represented as one of their best ideas. Those of you who attended the 2019 MicroCap Rodeo in Austin, Texas, know that we're focused on alpha.

About IMAC Holdings, Inc. 

IMAC Holdings owns and manages health and wellness centers that deliver sports medicine, orthopedic, and life science therapies for movement restricting diseases. IMAC is comprised of three business segments: outpatient medical centers, the BACKSPACE, and a clinical research division. With treatments to address the aging population, IMAC Holdings owns or manages more than 15 outpatient medical clinics and has partnered with several active and former professional athletes, including Ozzie Smith, David Price, Mike Ditka and Tony Delk to promote a minimally-invasive approach to sports medicine. IMAC’s the BACKSPACE retail spine health and wellness treatment centers deliver chiropractic care within Walmart locations. IMAC’s research division is currently conducting a Phase I clinical trial evaluating a mesenchymal stem cell therapy candidate for bradykinesia due to Parkinson’s disease. For more information visit

Contact:

IMAC Press Contact:

Laura Fristoe

Investor Relations:

Bret Shapiro

(516) 222-2560

SOURCE: IMAC Holdings, Inc. (Nasdaq: IMAC)



EN
28/09/2021

Underlying

IMACIMAC Holdings

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on IMAC Holdings

 PRESS RELEASE
Free
IMAC IMAC HOLDINGS

IMAC Holdings, Inc. Regains Compliance with Nasdaq Listing Requirement...

IMAC Holdings, Inc. Regains Compliance with Nasdaq Listing Requirements Franklin, TN, Sept. 27, 2023 (GLOBE NEWSWIRE) -- IMAC Holdings, Inc. (Nasdaq: BACK) (“IMAC” or the “Company”) today announced that it has received notice from The Nasdaq Stock Market LLC informing the Company that it has regained compliance with the minimum bid price requirement under Nasdaq Listing Rule 5550(a)(2) for continued listing on The Nasdaq Capital Market and that it is in compliance with all applicable listing standards. The Company’s common stock and warrants will continue to be listed and traded on The N...

September 27, 2023 1 EN
 PRESS RELEASE
Free
IMAC IMAC HOLDINGS

IMAC Holdings, Inc. Announces 1-for-30 Reverse Stock Split

IMAC Holdings, Inc. Announces 1-for-30 Reverse Stock Split Franklin, TN, Sept. 07, 2023 (GLOBE NEWSWIRE) -- IMAC Holdings, Inc. (Nasdaq: BACK) (“IMAC” or the “Company”) today announced a reverse stock split of its outstanding shares of common stock at a ratio of 1-for-30 (the “Reverse Split”) and that it had filed a Certificate of Amendment to the Company’s Certificate of Incorporation in order to effect the Reverse Split. The Reverse Split will be effective after the market closes on September 7, 2023. Beginning with the opening of trading on September 8, 2023, the Company’s common stock...

September 7, 2023 1 EN
 PRESS RELEASE
Free
IMAC IMAC HOLDINGS

IMAC Holdings Announces $4.3 Million Private Placement of Convertible ...

IMAC Holdings Announces $4.3 Million Private Placement of Convertible Preferred Stock and Warrants Priced at the Market Franklin, Tennessee, July 26, 2023 (GLOBE NEWSWIRE) -- IMAC Holdings, Inc. (Nasdaq: BACK) (“IMAC” or the “Company”), a provider of innovative medical advancements and care specializing in regenerative rehabilitation orthopedic treatments, announced today that it entered into a definitive securities purchase agreement with several institutional and accredited investors, including existing significant investors of Theralink Technologies, Inc., its previously announced merg...

July 26, 2023 1 EN
 PRESS RELEASE
Free
IMAC IMAC HOLDINGS

IMAC Holdings Annual Meeting of Shareholders Reminder

IMAC Holdings Annual Meeting of Shareholders Reminder Shareholders are reminded to vote their shares prior to the proxy voting deadline of 7:00pm on July 4, 2023 FRANKLIN, Tenn., June 28, 2023 (GLOBE NEWSWIRE) -- IMAC Holdings, Inc. (Nasdaq: BACK) (“IMAC”), a provider of innovative medical advancements and care specializing in regenerative rehabilitation orthopedic treatments without the use of surgery or opioids, reminds its shareholders that its Annual Meeting will be held July 5, 2023 at 11:00 am, local time, in Franklin, Tennessee. IMAC shareholders are encouraged to read the Proxy ...

June 28, 2023 1 EN
 PRESS RELEASE
Free
IMAC IMAC HOLDINGS

Theralink® Signs Definitive Merger Agreement to be Acquired by IMAC Ho...

Theralink® Signs Definitive Merger Agreement to be Acquired by IMAC Holdings, a Nasdaq Listed Company Theralink’s patented technology is helping to solve a significant problem in cancer treatment by providing game changing technology that can predict FDA-approved drugs that may be effective in each solid tumor cancer Golden, Colorado, May 23, 2023 (GLOBE NEWSWIRE) -- , Inc. (OTC: THER) (“Theralink”) and IMAC Holdings, Inc. (Nasdaq: BACK) (“IMAC”), today announced that they have entered into a definitive Agreement and Plan of Merger (the “Merger Agreement”) under which Theralink will merg...

May 23, 2023 1 EN

ResearchPool Subscriptions

Get the most out of your insights

Get in touch